Integragen

Integragen

ALINT · PA · Healthcare / Biotechnology

0.075EUR+0.00 (0.00%)

Price History

Full chart

Market Stats

Previous Close0.075
Open0.0652
Day Range0.065 – 0.075
52-Week Range0.0688 – 0.361
Volume0
Market Cap463.45K
P/E (TTM)0.00
Forward P/E0.00
EPS-0.04
Dividend Yield0.00%
Beta0.34
50-Day Avg0.1525
200-Day Avg0.1692

About

IntegraGen SA provides researchers with sequencing solutions, data management tools, and biostatistical, and bioinformatics support services in France. The company's genomic pharma services DNA sequencing for oncology and rare disease research; and NGS testing for cancer research. It also provides MERCURY, an online biological interpretation tool for oncology intended to assist pathologists and oncologists in transforming raw data obtained through high-throughput sequencing into a molecular report for translational and clinical research use; Galileo, a cloud-based app for dynamic exporation of RNA-Seq expression data; and GeCo, a genomic consulting service that offers researchers with access to biostatistics and bioanalytics experts. IntegraGen SA was incorporated in 2000 and is headquartered in Évry, France. IntegraGen SA operates as a subsidiary of OncoDNA SA.

Company Details

  • SectorHealthcare
  • IndustryBiotechnology
  • CEOMs. Berengere Genin
  • Employees37
  • HeadquartersGenopole Campus 1 BAt. 8, Évry, France, 91000, France
  • Websitehttps://integragen.com

Leadership

  • Ms. Berengere GeninGeneral Manager
  • Ms. Anne PhilippiCo-Founder and Director of Bio-Statistics & Genetic Epidemiology
  • Ms. Beatrice CosperecLegal Manager
  • Ms. Celine CaperaSales Manager
  • Manuelle PuisantDirector of Human Resources

Financials

Income Statement

Currency: EUR2008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue2.26M2.81M3.31M4.65M4.74M5.41M6.13M5.79M6.27M6.51M6.95M8.28M8.98M11.32M13.17M12.54M8.70M5.02M
Growth (%)-+24.48%+17.66%+40.47%+1.97%+14.17%+13.24%-5.57%+8.37%+3.77%+6.80%+19.12%+8.45%+26.11%+16.27%-4.78%-30.62%-42.27%
Cost of Revenue3.65M3.73M2.01M4.72M4.62M5.55M4.92M4.71M4.84M5.25M4.55M2.56M9.07M11.28M13.17M12.54M6.91M7.39M
Gross Profit-1.39M-914.47K1.30M-70.08K120.06K-140.54K1.21M1.08M1.44M1.26M2.40M5.72M-89.45K43.69K-6.36K-6.98K1.79M-2.37M
Gross Margin-61.31%-32.51%39.20%-1.51%2.53%-2.60%19.70%18.67%22.91%19.39%34.49%69.03%-1.00%0.39%-0.05%-0.06%20.53%-47.22%
Operating Expense1.26M1.92M4.11M2.33M2.49M2.75M2.89M3.39M3.22M3.19M3.58M6.08M164.69K73.24K132.77K176.79K2.59M451.60K
Operating Income-2.65M-2.84M-2.81M-2.40M-2.37M-2.89M-1.69M-2.31M-1.78M-1.93M-1.18M-363.00K-254.14K-29.55K-139.13K-183.76K-807.00K-2.82M
Operating Margin-117.08%-100.83%-84.83%-51.66%-49.94%-53.45%-27.51%-39.97%-28.36%-29.65%-16.97%-4.38%-2.83%-0.26%-1.06%-1.47%-9.28%-56.21%
EBITDA-3.21M-3.28M-3.48M-2.46M-2.31M-2.80M-1.61M-1.45M-1.67M-1.81M-1.20M-179.20K-235.89K96.45K69.96K-52.50K-296.00K-2.78M
EBITDA Margin-142.13%-116.55%-105.01%-52.87%-48.80%-51.78%-26.19%-24.97%-26.67%-27.76%-17.21%-2.16%-2.63%0.85%0.53%-0.42%-3.40%-55.32%
Net Income-3.03M-2.73M-2.90M-2.04M-1.73M-2.55M-1.04M-1.53M-1.65M-862.17K-1.14M-285.00K-375.02K15.41K-3.51K-171.40K-256.00K-2.66M
Net Income Margin-133.90%-97.18%-87.51%-43.88%-36.41%-47.03%-17.03%-26.50%-26.32%-13.25%-16.40%-3.44%-4.18%0.14%-0.03%-1.37%-2.94%-53.06%
Interest Expense519.67K6.25K4.09K22915.92K7501191501052.65K5.21K4.88K11.92K8.37K4.86K1.87K
Interest Expense % of Total Revenue23.00%0.22%0.12%0.00%0.34%0.00%0.00%0.00%0.00%0.00%0.00%0.03%0.06%0.04%0.09%0.07%0.06%0.04%

Balance Sheet

Currency: EUR2008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets3.58M4.19M8.18M6.97M7.85M5.78M9.17M8.62M7.59M8.65M8.58M6.75M8.82M9.60M9.02M8.00M5.51M2.81M
Total Liabilities2.10M2.91M3.05M3.87M4.62M5.09M5.41M5.69M6.31M4.72M5.79M4.24M6.65M7.42M6.82M5.99M3.76M2.71M
Total Equity1.48M1.28M5.13M3.09M3.24M691.87K3.76M2.93M1.28M3.93M2.79M2.51M2.17M2.19M2.20M2.01M1.75M-909.00K
Cash49.84K437.42K220.33K634.41K321.59K444.65K683.13K1.48M549.11K1.34M735.01K2.81M1.02M2.94M2.46M1.83M1.90M1.11M
Total Debt23090.13K42.38K1.54M18595254157323343358.84K300.57K2.08M2.27M1.67M1.12M643.00K305.00K
Net Debt-49.61K-347.29K-177.95K910.57K-321.40K-444.56K-682.88K-1.48M-548.95K-1.34M-435.01K-2.57M996.28K-983.73K-787.65K-709.75K-1.26M-810.00K

Cash Flow

Currency: EUR2012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow-1.47M-2.49M--105.63K123.30K135.90K256.10K452.69K411.78K403.11K---1.58M
Investing Cash Flow-25.30K39.20K---332.88K--------40.24K
Financing Cash Flow1.69M293.16K-----------748.71K
Capital Expenditure74.49K72.13K00332.88K000000002.27K
Free Cash Flow-1.54M-2.56M---227.25K123.30K135.90K256.10K452.69K411.78K403.11K---1.58M
FCF to OCF105.08%102.90%---215.15%100.00%100.00%100.00%100.00%100.00%100.00%--100.14%

Earnings

Report DateOct 18, 2016Apr 21, 2017Oct 5, 2017Apr 13, 2018Sep 20, 2018Apr 18, 2019Nov 15, 2019Apr 28, 2020Sep 18, 2020Apr 19, 2021Oct 8, 2021Apr 29, 2022Oct 18, 2022Apr 24, 2023Jul 30, 2024Apr 29, 2025Oct 30, 2025
EPS Estimate0.000.000.000.000.000.000.000.000.000.000.000.00-0.000.000.000.00
EPS Actual-0.20-0.12-0.10-0.08-0.08-0.09-0.080.040.00-0.06-0.060.07-0.020.02-0.020.000.00
Surprise-----------------
Timing-Pre-market-Pre-marketAfter-hoursPre-marketPre-marketPre-market-Pre-market--After-hoursAfter-hours---

Key Statistics & Ratios

Market Cap463.45K
Enterprise Value-323.74K
Trailing P/E0.00
Forward P/E0.00
PEG Ratio0.00
Price / Sales0.09
Price / Book3.57
EPS-0.04
Book Value-0.138
Revenue (TTM)5.02M
Gross Profit (TTM)1.06M
EBITDA-2.71M
Profit Margin-53.06%
Operating Margin-56.57%
Return on Equity-629.40%
Return on Assets-41.35%
Shares Outstanding6.61M
Shares Float2.36M
Beta0.34
Dividend Yield0.00%
Dividend Rate0.00
Payout Ratio0.00%